Message from Provost Blouin on Eshelman School of Pharmacy dean
Angela Kashuba, who has played a key role in the school’s success for over two decades, has been selected as the next dean of the UNC Eshelman School of Pharmacy.
Dear Carolina Community,
I am pleased to announce that Angela Kashuba, a world-renowned researcher, skilled administrator and dedicated faculty member, has been selected as the next dean of the UNC Eshelman School of Pharmacy. The appointment, effective Oct. 1, is pending final approval by the University’s Board of Trustees.
Angela, currently the John and Deborah McNeill Jr. Distinguished Professor, has played a key role in the school’s success for over two decades. Now, at a time of rapid change and intense competition, I know from working with Angela for years that she is ideally suited to lead our internationally recognized school forward while maintaining our strong commitment to enhancing the health of North Carolinians.
For the past four years, Angela has served as chair of the Division of Pharmacotherapy and Experimental Therapeutics. Her acclaimed HIV and AIDS research focuses on topics including the role of antiretroviral therapy in preventing the transmission of HIV, along with the optimal dosing and drug combinations for treating HIV infection. She works to better understand and predict the distribution of drugs throughout the body, the interactions between drugs, and the roles that sex and ethnicity play in the way drugs are processed by the body.
Author of more than 240 peer-reviewed publications and an investigator awarded over $20 million in research funding, Angela serves as director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.
Angela joined the UNC-Chapel Hill faculty in 1997. After earning her bachelor of science degree in pharmacy at the University of Toronto, Angela completed a general practice residency at Women’s College Hospital and practiced as a critical care pharmacist at Mount Sinai Hospital, in Toronto, Canada. She then received her Pharm.D. from the State University of New York at Buffalo and completed postdoctoral pharmacology training at the Clinical Pharmacology Research Center at Bassett Healthcare in Cooperstown, New York.
I want to thank Dhiren Thakker, interim dean and interim director of the Eshelman Institute for Innovation, for his outstanding service in these roles since September 2017. We are grateful for his exceptional commitment to the UNC Eshelman School of Pharmacy community and the University.
Please join me in congratulating Angela on her appointment and in celebrating this important milestone for UNC Eshelman.
Sincerely,
Robert A. Blouin
Executive Vice Chancellor and Provost
